Literature DB >> 20150243

Analysis of the liver mitochondrial proteome in response to ethanol and S-adenosylmethionine treatments: novel molecular targets of disease and hepatoprotection.

Kelly K Andringa1, Adrienne L King, Heather B Eccleston, Sudheer K Mantena, Aimee Landar, Nirag C Jhala, Dale A Dickinson, Giuseppe L Squadrito, Shannon M Bailey.   

Abstract

S-adenosylmethionine (SAM) minimizes alcohol hepatotoxicity; however, the molecular mechanisms responsible for SAM hepatoprotection remain unknown. Herein, we use proteomics to determine whether the hepatoprotective action of SAM against early-stage alcoholic liver disease is linked to alterations in the mitochondrial proteome. For this, male rats were fed control or ethanol-containing liquid diets +/- SAM and liver mitochondria were prepared for proteomic analysis. Two-dimensional isoelectric focusing (2D IEF/SDS-PAGE) and blue native gel electrophoresis (BN-PAGE) were used to determine changes in matrix and oxidative phosphorylation (OxPhos) proteins, respectively. SAM coadministration minimized alcohol-dependent inflammation and preserved mitochondrial respiration. SAM supplementation preserved liver SAM levels in ethanol-fed rats; however, mitochondrial SAM levels were increased by ethanol and SAM treatments. With use of 2D IEF/SDS-PAGE, 30 proteins showed significant changes in abundance in response to ethanol, SAM, or both. Classes of proteins affected by ethanol and SAM treatments were chaperones, beta oxidation proteins, sulfur metabolism proteins, and dehydrogenase enzymes involved in methionine, glycine, and choline metabolism. BN-PAGE revealed novel changes in the levels of 19 OxPhos proteins in response to ethanol, SAM, or both. Ethanol- and SAM-dependent alterations in the proteome were not linked to corresponding changes in gene expression. In conclusion, ethanol and SAM treatment led to multiple changes in the liver mitochondrial proteome. The protective effects of SAM against alcohol toxicity are mediated, in part, through maintenance of proteins involved in key mitochondrial energy conserving and biosynthetic pathways. This study demonstrates that SAM may be a promising candidate for treatment of alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20150243      PMCID: PMC2867419          DOI: 10.1152/ajpgi.00332.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  65 in total

1.  Systematic characterization of the murine mitochondrial proteome using functionally validated cardiac mitochondria.

Authors:  Jun Zhang; Xiaohai Li; Michael Mueller; Yueju Wang; Chenggong Zong; Ning Deng; Thomas M Vondriska; David A Liem; Jeong-In Yang; Paavo Korge; Henry Honda; James N Weiss; Rolf Apweiler; Peipei Ping
Journal:  Proteomics       Date:  2008-04       Impact factor: 3.984

Review 2.  The structure and function of mitochondrial F1F0-ATP synthases.

Authors:  Rodney J Devenish; Mark Prescott; Andrew J W Rodgers
Journal:  Int Rev Cell Mol Biol       Date:  2008       Impact factor: 6.813

Review 3.  Role of the proteasome in ethanol-induced liver pathology.

Authors:  Terrence M Donohue; Arthur I Cederbaum; Samuel W French; Shirish Barve; Bin Gao; Natalia A Osna
Journal:  Alcohol Clin Exp Res       Date:  2007-09       Impact factor: 3.455

4.  Catalase takes part in rat liver mitochondria oxidative stress defense.

Authors:  Mauro Salvi; Valentina Battaglia; Anna Maria Brunati; Nicoletta La Rocca; Elena Tibaldi; Paola Pietrangeli; Lucia Marcocci; Bruno Mondovì; Carlo A Rossi; Antonio Toninello
Journal:  J Biol Chem       Date:  2007-06-18       Impact factor: 5.157

5.  Tissue distribution, ontogeny, and regulation of aldehyde dehydrogenase (Aldh) enzymes mRNA by prototypical microsomal enzyme inducers in mice.

Authors:  Yazen Alnouti; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2007-11-12       Impact factor: 4.849

Review 6.  ER chaperones in mammalian development and human diseases.

Authors:  Min Ni; Amy S Lee
Journal:  FEBS Lett       Date:  2007-04-25       Impact factor: 4.124

7.  Biological actions of lipoic acid associated with sulfane sulfur metabolism.

Authors:  Anna Bilska; Magdalena Dudek; Małgorzata Iciek; Inga Kwiecień; Maria Sokołowska-Jezewicz; Barbara Filipek; Lidia Włodek
Journal:  Pharmacol Rep       Date:  2008 Mar-Apr       Impact factor: 3.024

8.  S-adenosylmethionine and proliferation: new pathways, new targets.

Authors:  Nuria Martínez-López; Marta Varela-Rey; Usue Ariz; Nieves Embade; Mercedes Vazquez-Chantada; David Fernandez-Ramos; Laura Gomez-Santos; Shelly C Lu; Jose M Mato; Maria L Martinez-Chantar
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

9.  Mitochondrial protein thiol modifications in acetaminophen hepatotoxicity: effect on HMG-CoA synthase.

Authors:  Kelly K Andringa; Mary Lynn Bajt; Hartmut Jaeschke; Shannon M Bailey
Journal:  Toxicol Lett       Date:  2008-01-31       Impact factor: 4.372

Review 10.  Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases.

Authors:  Sudheer K Mantena; Adrienne L King; Kelly K Andringa; Heather B Eccleston; Shannon M Bailey
Journal:  Free Radic Biol Med       Date:  2008-01-03       Impact factor: 7.376

View more
  26 in total

Review 1.  Nutritional models of foetal programming and nutrigenomic and epigenomic dysregulations of fatty acid metabolism in the liver and heart.

Authors:  Jean-Louis Guéant; Rania Elakoum; Olivier Ziegler; David Coelho; Eva Feigerlova; Jean-Luc Daval; Rosa-Maria Guéant-Rodriguez
Journal:  Pflugers Arch       Date:  2013-09-03       Impact factor: 3.657

2.  Nongradient blue native gel analysis of serum proteins and in-gel detection of serum esterase activities.

Authors:  Nopporn Thangthaeng; Nathalie Sumien; Michael J Forster; Ruchir A Shah; Liang-Jun Yan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-12-31       Impact factor: 3.205

3.  Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice.

Authors:  Heather B Eccleston; Kelly K Andringa; Angela M Betancourt; Adrienne L King; Sudheer K Mantena; Telisha M Swain; Heather N Tinsley; Ryan N Nolte; Tim R Nagy; Gary A Abrams; Shannon M Bailey
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

4.  Involvement of the mitochondrial permeability transition pore in chronic ethanol-mediated liver injury in mice.

Authors:  Adrienne L King; Telisha M Swain; Zhengkuan Mao; Uduak S Udoh; Claudia R Oliva; Angela M Betancourt; Corrine E Griguer; David R Crowe; Mathieu Lesort; Shannon M Bailey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-12-19       Impact factor: 4.052

Review 5.  Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression.

Authors:  Karen D Corbin; Steven H Zeisel
Journal:  Curr Opin Gastroenterol       Date:  2012-03       Impact factor: 3.287

6.  Chronic ethanol consumption enhances sensitivity to Ca(2+)-mediated opening of the mitochondrial permeability transition pore and increases cyclophilin D in liver.

Authors:  Adrienne L King; Telisha M Swain; Dale A Dickinson; Mathieu J Lesort; Shannon M Bailey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-22       Impact factor: 4.052

7.  Hepatic Mitochondrial Defects in a Nonalcoholic Fatty Liver Disease Mouse Model Are Associated with Increased Degradation of Oxidative Phosphorylation Subunits.

Authors:  Kwangwon Lee; Andrew Haddad; Abdullah Osme; Chunki Kim; Ahmad Borzou; Sergei Ilchenko; Daniela Allende; Srinivasan Dasarathy; Arthur McCullough; Rovshan G Sadygov; Takhar Kasumov
Journal:  Mol Cell Proteomics       Date:  2018-08-31       Impact factor: 5.911

Review 8.  Vitamin-dependent methionine metabolism and alcoholic liver disease.

Authors:  Charles H Halsted; Valentina Medici
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 9.  S-adenosylmethionine in liver health, injury, and cancer.

Authors:  Shelly C Lu; José M Mato
Journal:  Physiol Rev       Date:  2012-10       Impact factor: 37.312

Review 10.  Convergent mechanisms for dysregulation of mitochondrial quality control in metabolic disease: implications for mitochondrial therapeutics.

Authors:  Tanecia Mitchell; Balu Chacko; Scott W Ballinger; Shannon M Bailey; Jianhua Zhang; Victor Darley-Usmar
Journal:  Biochem Soc Trans       Date:  2013-02-01       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.